140 related articles for article (PubMed ID: 6307500)
21. [Clinical experience with alpha and beta interferon in childhood cancer].
Ise T; Ohira M; Takayama J; Hanada M; Muchi H; Fukuma H; Beppu Y; Nomura K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1855-62. PubMed ID: 6591860
[TBL] [Abstract][Full Text] [Related]
22. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic hepatitis C with weekly administration of interferon-alpha.
Morizane T; Kagawa T; Saito H; Guevara FM; Miyaguchi S; Tsuchiya M
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():254-5. PubMed ID: 1909275
[TBL] [Abstract][Full Text] [Related]
24. Clinical effect of interferon in malignant brain tumours.
Nagai M; Arai T
Neurosurg Rev; 1984; 7(1):55-64. PubMed ID: 6379511
[TBL] [Abstract][Full Text] [Related]
25. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma.
Marumo K; Murai M; Hayakawa M; Tazaki H
Urology; 1984 Dec; 24(6):567-71. PubMed ID: 6506397
[TBL] [Abstract][Full Text] [Related]
26. Treatment of common and plantar viral warts with human lymphoblastoid interferon-alpha--pilot studies with intralesional, intramuscular and dermojet injections.
Gibson JR; Harvey SG; Kemmett D; Salisbury J; Marks P
Br J Dermatol; 1986 Aug; 115 Suppl 31():76-9. PubMed ID: 3741803
[TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
28. Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer.
Quesada JR; Gutterman JU; Hersh EM
J Interferon Res; 1982; 2(4):593-9. PubMed ID: 7142762
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha 2 interferon in patients with malignancies.
Shah I; Band J; Samson M; Young J; Robinson R; Bailey B; Lerner AM; Prasad AS
Am J Hematol; 1984; 17(4):363-71. PubMed ID: 6594039
[TBL] [Abstract][Full Text] [Related]
30. Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers.
Kirkwood JM; Ernstoff MS; Davis CA; Reiss M; Ferraresi R; Rudnick SA
Ann Intern Med; 1985 Jul; 103(1):32-6. PubMed ID: 4003987
[TBL] [Abstract][Full Text] [Related]
31. Large-scale production of human interferon from lymphoblastoid cells.
Phillips AW; Finter NB; Burman CJ; Ball GD
Methods Enzymol; 1986; 119():35-8. PubMed ID: 3020349
[No Abstract] [Full Text] [Related]
32. Human alpha-lymphoblastoid interferon. A phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs).
Sarna G; Figlin R; Bryson Y; Garratty E; Myers L; Le Fevre C; Mauritzon N; Cline M
Am J Clin Oncol; 1985 Oct; 8(5):406-12. PubMed ID: 4061375
[TBL] [Abstract][Full Text] [Related]
33. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
Merchant RE; McVicar DW; Merchant LH; Young HF
J Neurooncol; 1992 Jan; 12(1):75-83. PubMed ID: 1541981
[TBL] [Abstract][Full Text] [Related]
34. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
[TBL] [Abstract][Full Text] [Related]
35. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha therapy of renal cancer.
Neidhart JA; Gagen MM; Young D; Tuttle R; Melink TJ; Ziccarrelli A; Kisner D
Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of human recombinant interferon-alpha I after i.v. infusion and im injection in African green monkeys.
Wills RJ; Soike KF
J Interferon Res; 1988 Aug; 8(4):427-32. PubMed ID: 3171243
[TBL] [Abstract][Full Text] [Related]
38. Management of cancer patients receiving interferon alfa-2a.
Gauci L
Int J Cancer Suppl; 1987; 1():21-30. PubMed ID: 3476474
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of condyloma acuminata using human lymphoblastoid interferon].
Kinukawa T; Hattori R; Furukawa T; Ohshima S; Matsuura O; Takeuchi N; Tanaka K; Hashimoto J; Ono Y; Watanabe J
Hinyokika Kiyo; 1990 Nov; 36(11):1295-300. PubMed ID: 2288309
[TBL] [Abstract][Full Text] [Related]
40. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma].
Fukuzawa Y; Kawamura T; Ohno R
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3581-6. PubMed ID: 2817909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
